SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : DAVID SIRK's VALUE MOMENTUM PLAYS

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: onza who wrote (156)4/15/1999 5:46:00 PM
From: onza  Read Replies (1) of 4828
 
APPI: APPI's current product line consists of their cholesterol lowering agent ''Lo-Chol'', Immune system enhancer ''ACA'' and Garlic. Lo-Chol is a patented combination of six different botanicals and has been shown to not only lower total cholesterol and triglycerides, but also increase HDL (good cholesterol) and balance the proportion of HDL to LDL (bad cholesterol). ACA the nutritional version of Abavca (which received an IND from the FDA for a whole plant product) is the Company's most clinically advanced pharmaceutical. ACA is derived exclusively from whole plants and has been shown to overcome many of the debilitating symptoms of HIV patients and CFS (Chronic Fatigue Syndrome) while enhancing the immune system. All APPI products are completely natural, standardized and pharmaceutical grade. APPI products are manufactured utilizing APPI's patent pending 13 step proprietary process which creates the best nutritional supplements known to man. Most nutritional manufacturers extract active ingredients from plants using alcohol which castrates the original chemical formation of the plant. APPI does not extract active ingredients they utilize the whole plant leaving the original chemical formation of the plant in tact therefor offering more ingredients. A good comparison to the layman is APPI offers the apple other nutritional manufacturers offer the apple juice.

The total nutritional supplement market is estimated to be in excess of 23 billion dollars annually in the USA. The CFS and Immune markets are estimated to be in excess of 6 billion dollars annually. The cholesterol market in the USA is estimated to be in excess of 4 billion annually.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext